Navidea Biopharmaceuticals, Inc. (NAVB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -0.59 USD | -47.5% |
| 2021 | -0.40 USD | 11.11% |
| 2020 | -0.45 USD | 40.79% |
| 2019 | -0.76 USD | 59.79% |
| 2018 | -1.89 USD | -120.11% |
| 2017 | 9.40 USD | 610.87% |
| 2016 | -1.84 USD | 49.59% |
| 2015 | -3.65 USD | 23.96% |
| 2014 | -4.80 USD | 31.53% |
| 2013 | -7.01 USD | -19.02% |
| 2012 | -5.89 USD | -590.83% |
| 2011 | 1.20 USD | 109.69% |
| 2010 | -12.38 USD | -15.27% |
| 2009 | -10.74 USD | -611.26% |
| 2008 | -1.51 USD | 6.79% |
| 2007 | -1.62 USD | 0.0% |
| 2006 | -1.62 USD | 4.14% |
| 2005 | -1.69 USD | -35.2% |
| 2004 | -1.25 USD | -40.45% |
| 2003 | -0.89 USD | 45.73% |
| 2002 | -1.64 USD | -14360.87% |
| 2001 | 0.01 USD | -98.56% |
| 2000 | 0.80 USD | 122.04% |
| 1999 | -3.63 USD | 85.21% |
| 1998 | -24.54 USD | -20.0% |
| 1997 | -20.45 USD | 3.4% |
| 1996 | -21.17 USD | -36.14% |
| 1995 | -15.55 USD | 34.11% |
| 1994 | -23.60 USD | -4.42% |
| 1993 | -22.60 USD | -175.61% |
| 1992 | -8.20 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q2 | 0.12 USD | 593.83% |
| 2023 Q1 | -0.02 USD | 85.71% |
| 2023 Q3 | -0.02 USD | -118.92% |
| 2022 Q3 | -0.19 USD | -91.73% |
| 2022 Q4 | -0.17 USD | 10.53% |
| 2022 FY | - USD | -47.5% |
| 2022 Q1 | -0.10 USD | 17.33% |
| 2022 Q2 | -0.10 USD | 0.1% |
| 2021 Q3 | -0.08 USD | 11.87% |
| 2021 Q4 | -0.12 USD | -48.33% |
| 2021 Q2 | -0.09 USD | 16.55% |
| 2021 FY | - USD | 11.11% |
| 2021 Q1 | -0.11 USD | 0.0% |
| 2020 Q4 | -0.11 USD | 0.0% |
| 2020 FY | - USD | 40.79% |
| 2020 Q1 | -0.13 USD | 13.33% |
| 2020 Q2 | -0.10 USD | 23.08% |
| 2020 Q3 | -0.11 USD | -10.0% |
| 2019 Q1 | -0.24 USD | 27.27% |
| 2019 FY | - USD | 59.79% |
| 2019 Q4 | -0.15 USD | 11.76% |
| 2019 Q3 | -0.17 USD | 29.17% |
| 2019 Q2 | -0.24 USD | 0.0% |
| 2018 FY | - USD | -120.11% |
| 2018 Q4 | -0.33 USD | 28.26% |
| 2018 Q3 | -0.46 USD | -58.62% |
| 2018 Q2 | -0.29 USD | 65.06% |
| 2018 Q1 | -0.83 USD | -66.0% |
| 2017 Q3 | -0.18 USD | 72.73% |
| 2017 Q4 | -0.50 USD | -177.78% |
| 2017 Q2 | -0.66 USD | -106.23% |
| 2017 FY | - USD | 610.87% |
| 2017 Q1 | 10.60 USD | 2220.0% |
| 2016 Q2 | -0.86 USD | -82.98% |
| 2016 FY | - USD | 49.59% |
| 2016 Q4 | -0.50 USD | -6478.95% |
| 2016 Q3 | -0.01 USD | 99.12% |
| 2016 Q1 | -0.47 USD | -46.87% |
| 2015 FY | - USD | 23.96% |
| 2015 Q4 | -0.32 USD | 70.09% |
| 2015 Q2 | -1.29 USD | -32.99% |
| 2015 Q3 | -1.07 USD | 17.05% |
| 2015 Q1 | -0.97 USD | -5.43% |
| 2014 Q3 | -0.92 USD | 32.35% |
| 2014 Q2 | -1.36 USD | 16.05% |
| 2014 FY | - USD | 31.53% |
| 2014 Q1 | -1.62 USD | 20.98% |
| 2014 Q4 | -0.92 USD | 0.0% |
| 2013 FY | - USD | -19.02% |
| 2013 Q4 | -2.05 USD | -9.63% |
| 2013 Q2 | -1.74 USD | -34.88% |
| 2013 Q3 | -1.87 USD | -7.47% |
| 2013 Q1 | -1.29 USD | 6.52% |
| 2012 FY | - USD | -590.83% |
| 2012 Q4 | -1.38 USD | 22.47% |
| 2012 Q3 | -1.78 USD | -44.72% |
| 2012 Q2 | -1.23 USD | 17.45% |
| 2012 Q1 | -1.49 USD | 8.02% |
| 2011 Q2 | -0.49 USD | 52.88% |
| 2011 FY | - USD | 109.69% |
| 2011 Q4 | -1.62 USD | -138.57% |
| 2011 Q3 | 4.20 USD | 957.14% |
| 2011 Q1 | -1.04 USD | -108.0% |
| 2010 Q2 | -10.73 USD | -1630.65% |
| 2010 Q3 | -0.59 USD | 94.5% |
| 2010 Q4 | -0.50 USD | 15.25% |
| 2010 FY | - USD | -15.27% |
| 2010 Q1 | -0.62 USD | -740.11% |
| 2009 FY | - USD | -611.26% |
| 2009 Q4 | -0.07 USD | 98.9% |
| 2009 Q2 | -4.24 USD | -2220.0% |
| 2009 Q3 | -6.72 USD | -58.49% |
| 2009 Q1 | 0.20 USD | 157.14% |
| 2008 Q3 | -0.55 USD | -83.33% |
| 2008 Q2 | -0.30 USD | 0.0% |
| 2008 Q1 | -0.30 USD | 47.37% |
| 2008 Q4 | -0.35 USD | 36.36% |
| 2008 FY | - USD | 6.79% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | -0.57 USD | -90.0% |
| 2007 Q3 | -0.30 USD | 18.92% |
| 2007 Q2 | -0.37 USD | 0.0% |
| 2007 Q1 | -0.37 USD | 15.91% |
| 2006 Q1 | -0.32 USD | 27.27% |
| 2006 FY | - USD | 4.14% |
| 2006 Q3 | -0.57 USD | -96.55% |
| 2006 Q2 | -0.29 USD | 9.38% |
| 2006 Q4 | -0.44 USD | 22.81% |
| 2005 FY | - USD | -35.2% |
| 2005 Q2 | -0.46 USD | -35.29% |
| 2005 Q4 | -0.44 USD | 0.0% |
| 2005 Q3 | -0.44 USD | 4.35% |
| 2005 Q1 | -0.34 USD | 56.96% |
| 2004 Q1 | -0.22 USD | 0.0% |
| 2004 Q2 | -0.15 USD | 31.82% |
| 2004 Q3 | -0.08 USD | 45.2% |
| 2004 Q4 | -0.79 USD | -861.07% |
| 2004 FY | - USD | -40.45% |
| 2003 Q1 | -0.25 USD | -190.36% |
| 2003 FY | - USD | 45.73% |
| 2003 Q4 | -0.22 USD | 35.29% |
| 2003 Q3 | -0.34 USD | -723.24% |
| 2003 Q2 | -0.04 USD | 83.48% |
| 2002 Q2 | -0.48 USD | -2.13% |
| 2002 Q1 | -0.47 USD | -30.56% |
| 2002 FY | - USD | -14360.87% |
| 2002 Q4 | -0.09 USD | 85.65% |
| 2002 Q3 | -0.60 USD | -25.0% |
| 2001 Q3 | 0.40 USD | 100.0% |
| 2001 FY | - USD | -98.56% |
| 2001 Q2 | 0.20 USD | 219.49% |
| 2001 Q1 | 0.06 USD | -88.82% |
| 2001 Q4 | -0.36 USD | -190.0% |
| 2000 Q4 | 0.56 USD | 40.0% |
| 2000 Q2 | 0.40 USD | 1986.79% |
| 2000 Q1 | -0.02 USD | -109.64% |
| 2000 FY | - USD | 122.04% |
| 2000 Q3 | 0.40 USD | 0.0% |
| 1999 Q3 | -1.46 USD | -21.67% |
| 1999 Q2 | -1.20 USD | -6.19% |
| 1999 Q4 | 0.22 USD | 115.07% |
| 1999 Q1 | -1.13 USD | 87.07% |
| 1999 FY | - USD | 85.21% |
| 1998 Q4 | -8.74 USD | -82.08% |
| 1998 Q1 | -6.20 USD | -18.1% |
| 1998 FY | - USD | -20.0% |
| 1998 Q2 | -4.60 USD | 25.81% |
| 1998 Q3 | -4.80 USD | -4.35% |
| 1997 Q2 | -6.40 USD | -52.38% |
| 1997 Q4 | -5.25 USD | -9.38% |
| 1997 Q3 | -4.80 USD | 25.0% |
| 1997 FY | - USD | 3.4% |
| 1997 Q1 | -4.20 USD | 47.17% |
| 1996 FY | - USD | -36.14% |
| 1996 Q4 | -7.95 USD | -89.29% |
| 1996 Q3 | -4.20 USD | 4.55% |
| 1996 Q2 | -4.40 USD | -10.0% |
| 1996 Q1 | -4.00 USD | 5.21% |
| 1995 Q3 | -3.20 USD | 11.11% |
| 1995 Q4 | -4.22 USD | -31.87% |
| 1995 FY | - USD | 34.11% |
| 1995 Q2 | -3.60 USD | 14.29% |
| 1995 Q1 | -4.20 USD | 38.14% |
| 1994 FY | - USD | -4.42% |
| 1994 Q1 | -6.20 USD | -1.81% |
| 1994 Q2 | -5.00 USD | 19.35% |
| 1994 Q3 | -8.00 USD | -60.0% |
| 1994 Q4 | -6.79 USD | 15.13% |
| 1993 Q4 | -6.09 USD | -17.12% |
| 1993 Q2 | -4.80 USD | -60.0% |
| 1993 Q3 | -5.20 USD | -8.33% |
| 1993 FY | - USD | -175.61% |
| 1993 Q1 | -3.00 USD | -26.58% |
| 1992 FY | - USD | 0.0% |
| 1992 Q3 | -2.60 USD | 0.0% |
| 1992 Q4 | -2.37 USD | 8.85% |
| Name | Eps | Eps Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -0.60 USD | 1.667% |
| Ampio Pharmaceuticals, Inc. | -10.67 USD | 94.47% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | 69.11% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | 67.76% |
| Azitra, Inc. | -54.76 USD | 98.923% |
| Can-Fite BioPharma Ltd. | -1.79 USD | 67.039% |
| Chromocell Therapeutics Corporation | -1.28 USD | 53.906% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | 65.896% |
| CEL-SCI Corporation | -0.73 USD | 19.178% |
| iBio, Inc. | -6.50 USD | 90.923% |
| Lineage Cell Therapeutics, Inc. | -0.12 USD | -391.667% |
| MAIA Biotechnology, Inc. | -1.49 USD | 60.403% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | 88.826% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 99.574% |
| NanoViricides, Inc. | -0.70 USD | 15.714% |
| Oragenics, Inc. | -9.18 USD | 93.573% |
| BiomX Inc. | -5.10 USD | 88.431% |
| BiomX Inc. | -5.10 USD | 88.431% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 591.667% |
| Palatin Technologies, Inc. | -2.02 USD | 70.792% |
| Scorpius Holdings, Inc. | -347.20 USD | 99.83% |